Resonance Health Ltd has released a press release.
Market Update
Filed with ASX ·
On 6ix: 6ix.com/news/market-update-139
6ix hasn’t read this filing yet.
Earlier from Resonance Health
- Controlled Placement Facility
- Licencee & Royalty Agreement with 3DR Laboratories
- Resonance Health Partners with Siemens Healthineers
- New AI Tool for Automated Assessment of Liver Fat
- Resonance Health Files Provisional Patent
Later from Resonance Health
- Resonance Health Files New Provisional Patent
- Execution of Licence Agreement
- New Pulmonary Embolism AI Solution Developed
- HepaFat-AI gains US FDA clearance
- HepaFat-AI Incorporated into Blackford Analysis
Follow Resonance Health into a list and get an email when it puts out news.
Follow Resonance Health